Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study

Saved in:
Bibliographic Details
Published in:Haematologica (Roma) Vol. 107; no. 6; pp. 1470 - 1473
Main Authors: Innocenti, Idanna, Reda, Gianluigi, Visentin, Andrea, Coscia, Marta, Motta, Marina, Murru, Roberta, Moia, Riccardo, Gentile, Massimo, Pennese, Elsa, Quaglia, Francesca Maria, Albano, Francesco, Cassin, Ramona, Deodato, Marina, Ielo, Claudia, Frustaci, Anna Maria, Piciocchi, Alfonso, Rughini, Arianna, Arena, Valentina, Di Sevo, Daniela, Tomasso, Annamaria, Autore, Francesco, Del Poeta, Giovanni, Scarfò, Lydia, Mauro, Francesca Romana, Tedeschi, Alessandra, Trentin, Livio, Pompili, Maurizio, Foà, Robin, Ghia, Paolo, Cuneo, Antonio, Laurenti, Luca
Format: Journal Article
Language:English
Published: Italy Fondazione Ferrata Storti 01-06-2022
Ferrata Storti Foundation
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:Disclosures
Study data were collected and managed using REDCAP (Research Electronic Data Capture), a web-based software platform designed to support data capture for research studies. The data presented in this study are not available. Study protocol can be required to the corresponding author (luca.laurenti@unicatt.it).
II, GR, AV, MC, MM, RM, RM, MG, EP, FMQ, FA, RC, MD, CI, AMF, AP, AR, VA, DDS, AT, FA, GDP, LS, FRM, AT, LT, MP, RF, PG, AC and LL collected the data; AP performed the statistical analysis. All the authors reviewed the manuscript for important intellectual contents, approved the final version of the manuscript and supervised the project.
Contributions
AV has participated in scientific board meetings held by Janssen; LT has participated in scientific board meetings and has received funding from Janssen. All other authors have no conflicts of interest to disclose.
Data sharing statement
ISSN:0390-6078
1592-8721
DOI:10.3324/haematol.2021.280325